MARÍA LUISA
NAVARRO GÓMEZ

Profesora asociada de Ciencias de la Salud

Foto de MARÍA LUISA

Foto de University of Padua

University of Padua

Padua, Italia

Publications in collaboration with researchers from University of Padua (3)

2023

Nucleoside/nucleotide reverse transcriptase inhibitor sparing regimen with once daily integrase inhibitor plus boosted darunavir is non-inferior to standard of care in virologically-suppressed children and adolescents living with HIV – Week 48 results of the randomised SMILE Penta-17-ANRS 152 clinical trial
eClinicalMedicine, Vol. 60

2012

Population pharmacokinetics and maximum a posteriori probability Bayesian estimator of abacavir: Application of individualized therapy in HIV-infected infants and toddlers
British Journal of Clinical Pharmacology, Vol. 73, Núm. 4, pp. 641-650

2008

Plasma drug concentrations and virologic evaluations after stopping treatment with nonnucleoside reverse-transcriptase inhibitors in HIV type 1-infected children
Clinical Infectious Diseases, Vol. 46, Núm. 10, pp. 1601-1608